ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 702415 Null 0.00126165886744894 -0.03709611
NSC 720065 Vedelianin 0.00126165886744894 0.50169528
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 0.00126165886744894 0.56532765
NSC 733883 6-(3-Chloropropyl)-5,6-dihydro-7-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.00126165886744894 0.51225047
NSC 76919 2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- 0.00126165886744894 0.69134743
NSC 249992 M-AMSA 0.00165587325865807 0.83096842
NSC 295500 Camptothecin Derivative 0.00165587325865807 0.75846897
NSC 660027 Null 0.00165587325865807 0.64208887
NSC 666850 Null 0.00165587325865807 0.11116499
NSC 673348 9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- 0.00165587325865807 0.36421841
Total:99  Current:6    [First] [Prev] [Next] [Last]